What does SOBABEL PHARMATECHNIC do?

SOBABEL PHARMATECHNIC is filed with the CBE under the catch-all “Niet-gespecialiseerde groothandel”, a code that says little about what the company actually does. Private Limited, started on 30 March 2015, 1 establishment.

What is the address of SOBABEL PHARMATECHNIC?

The registered office of SOBABEL PHARMATECHNIC is located at Doornikserijksweg(Bel) 226-228, 8510 Kortrijk.

Is SOBABEL PHARMATECHNIC still active?

Yes. According to the CBE (16 September 2026) SOBABEL PHARMATECHNIC is active, legal situation “Normale toestand”, started on 30 March 2015.

Is SOBABEL PHARMATECHNIC registered on Peppol?

Yes, SOBABEL PHARMATECHNIC is registered on the Peppol network with ID 0208:0627679872.

What is the enterprise number of SOBABEL PHARMATECHNIC?

The enterprise number of SOBABEL PHARMATECHNIC is BE0627679872.

When was SOBABEL PHARMATECHNIC founded?

SOBABEL PHARMATECHNIC was founded on 30 March 2015.

Who are the directors of SOBABEL PHARMATECHNIC?

According to the 2024 annual accounts, the directors of SOBABEL PHARMATECHNIC are: Bart CLEMENT, Françoise OSTYN.

Is SOBABEL PHARMATECHNIC a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 March 2015; 4 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did SOBABEL PHARMATECHNIC make in 2024?

SOBABEL PHARMATECHNIC posted a profit after taxes of € 45,629 in financial year 2024.

What is the revenue of SOBABEL PHARMATECHNIC?

As a small company, SOBABEL PHARMATECHNIC is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 81,584.

How many employees does SOBABEL PHARMATECHNIC have?

According to the 2024 annual accounts, SOBABEL PHARMATECHNIC has 0 full-time equivalents (FTE).

Does SOBABEL PHARMATECHNIC have a website?

Yes, SOBABEL PHARMATECHNIC has a website at sobabel.be.

SOBABEL PHARMATECHNIC (Private Limited) - Kortrijk

Dossier SOBABEL PHARMATECHNIC, printed on 16 September 2026 from databakkes.be/en/0627679872/sobabel-pharmatechnic. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

SOBABEL PHARMATECHNIC from Kortrijk, company number BE0627679872, closed financial year 2024 with a result of € 45,629 after tax. For that financial year SOBABEL PHARMATECHNIC recorded a gross margin of € 81,584 and equity of € 211,794. Compared with financial year 2023, the result moved from € 27,029 to € 45,629. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 7, 2025.

What it is worth Growing

€ 211,794

▲ 27% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 45,629

▲ 69% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 25,925

▼ 25% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 11,794.

People and assets in 2024

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 719

▲ 27% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 12,893

▼ 64% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 14,769

▼ 29% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ -5,583 Gross margin 2021: € -5,583 First fiscal year in the series	€ 47,723 Gross margin 2022: € 47,723 ▲ € 53,306 vs 2021 (€ -5,583) Favourable step	€ 51,633 Gross margin 2023: € 51,633 ▲ 8% vs 2022 (€ 47,723) Favourable step	€ 81,584 Gross margin 2024: € 81,584 ▲ 58% vs 2023 (€ 51,633) Favourable step	▲ 58%
Profit after taxes	€ -28,438 Profit after taxes 2021: € -28,438 First fiscal year in the series	€ 24,168 Profit after taxes 2022: € 24,168 ▲ € 52,606 vs 2021 (€ -28,438) Favourable step	€ 27,029 Profit after taxes 2023: € 27,029 ▲ 12% vs 2022 (€ 24,168) Favourable step	€ 45,629 Profit after taxes 2024: € 45,629 ▲ 69% vs 2023 (€ 27,029) Favourable step	▲ 69%
Equity	€ 114,968 Equity 2021: € 114,968 First fiscal year in the series	€ 139,136 Equity 2022: € 139,136 ▲ 21% vs 2021 (€ 114,968) Favourable step	€ 166,165 Equity 2023: € 166,165 ▲ 19% vs 2022 (€ 139,136) Favourable step	€ 211,794 Equity 2024: € 211,794 ▲ 27% vs 2023 (€ 166,165) Favourable step	▲ 27%
Total debts	€ 333,168 Total debts 2021: € 333,168 First fiscal year in the series	€ 251,729 Total debts 2022: € 251,729 ▼ 24% vs 2021 (€ 333,168) Favourable step	€ 241,800 Total debts 2023: € 241,800 ▼ 4% vs 2022 (€ 251,729) Favourable step	€ 55,271 Total debts 2024: € 55,271 ▼ 77% vs 2023 (€ 241,800) Favourable step	▼ 77%
Cash	€ 22,102 Cash 2021: € 22,102 First fiscal year in the series	€ 14,481 Cash 2022: € 14,481 ▼ 34% vs 2021 (€ 22,102) Unfavourable step	€ 34,546 Cash 2023: € 34,546 ▲ 139% vs 2022 (€ 14,481) Favourable step	€ 25,925 Cash 2024: € 25,925 ▼ 25% vs 2023 (€ 34,546) Unfavourable step	▼ 25%
Retained profit	€ -85,032 Retained profit 2021: € -85,032 First fiscal year in the series	€ -60,864 Retained profit 2022: € -60,864 ▲ € 24,168 vs 2021 (€ -85,032) Favourable step	€ -33,835 Retained profit 2023: € -33,835 ▲ € 27,029 vs 2022 (€ -60,864) Favourable step	€ 11,794 Retained profit 2024: € 11,794 ▲ € 45,629 vs 2023 (€ -33,835) Favourable step	▲ € 45,629
Balance sheet total	€ 448,136 Balance sheet total 2021: € 448,136 First fiscal year in the series	€ 390,865 Balance sheet total 2022: € 390,865 ▼ 13% vs 2021 (€ 448,136) Unchanged	€ 407,965 Balance sheet total 2023: € 407,965 ▲ 4% vs 2022 (€ 390,865) Unchanged	€ 267,065 Balance sheet total 2024: € 267,065 ▼ 35% vs 2023 (€ 407,965) Unchanged	▼ 35%

Key figures of SOBABEL PHARMATECHNIC, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 30 April 2026.

What happened to SOBABEL PHARMATECHNIC?

What happened at SOBABEL PHARMATECHNIC in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 7, 2025 New annual accounts for financial year 2024: profit of € 45,629 (▲ 69% vs 2023). Source: NBB ↗
Mar 30, 2015 New establishment in Kortrijk. KBO
Mar 30, 2015 Start of the company according to the CBE. KBO

In short

From € 28,438 loss in 2021 to € 45,629 profit in 2024.

Paid € 26,810 in corporate taxes since 2021.

Best year ever: 2024, with € 45,629 profit.

Original PDFs at the National Bank ↗

A new publication or filing at SOBABEL PHARMATECHNIC? We notify you, reason included.

Follow SOBABEL PHARMATECHNIC

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Bart CLEMENT Françoise OSTYN

CBF PROJECTS

SOBABEL PHARMATECHNIC

Behind SOBABEL PHARMATECHNIC are Bart CLEMENT and Françoise OSTYN. The same people are also behind CBF PROJECTS.

See the full network in the app

Directors

According to the 2024 annual accounts

Bart CLEMENT

Director

Also active at: CBF PROJECTS

Françoise OSTYN

Director

Also active at: CBF PROJECTS

Establishments

Establishment units

Physical locations of this company

Registered office

Doornikserijksweg(Bel) 226-228

8510 Kortrijk

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

CBF PROJECTS same network

€ 104,203 gross margin · 2025

CLEMENT - OSTYN

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS sobabel.be

Technologies

Adobe FontsApacheCloudflare CDNJSGoogle Tag ManagerPHPPWAjQueryunpkg

Hosting & Email

Email provider

Microsoft 365

Hosting

CYSO-AS, NL

Website info

HTTPS Ja

Indexable pages 28

Languages NL

Features

Ads Contact page

Security

✓ HTTPS

✓ SPF

✓ DMARC

Details

Company number: 0627.679.872
VAT number: BE 0627.679.872
Registered office: Doornikserijksweg(Bel) 226-228, 8510 Kortrijk
Names & denominations: SOBABEL PHARMATECHNIC
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 30 March 2015
Peppol: Active · Active since 31 Dec 2025
Contact: sobabel.be
Activities · NACE: Niet-gespecialiseerde groothandel

View on CBE Public ↗ Annual accounts (NBB) ↗